- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05966077
Impact of Sending an Sms on the Rate of Telephone Responses of Subjects Contacted 3 Months After the Suicidal Act (EVAREST3)
Impact of Sending an Sms in the "Vigilans Lorraine" Monitoring System on the Rate of Telephone Responses of Subjects Contacted 3 Months After a Passage to the Suicidal Act
The objective of this controlled, randomized, monocentric study is to compare the response rate of the call at 3 months of the groups with or without short message service (SMS) 48 hours before, for the subjects having benefited from the device "VigilanS Lorraine". The secondary objectives will be to appreciate the satisfaction of the subjects towards the sending of the SMS as well as to compare the delay of suicidal recidivism according to whether the subjects answered or not to the call of evaluation at 3 months of the passage to the act The main question it aims to answer is: What impact, on the rate of successful calls, could sending a text message 48 hours before the 3-month evaluation phone call have on subjects benefiting from the VigilanS device?
The participants will be divided into 2 groups:
- 1st group: SMS sent 48 hours before the 3-month evaluation call planned in the framework of the "VigilanS Lorraine" program.
- 2nd group (control): evaluation call at 3 months planned within the framework of the "VigilanS Lorraine" system, not preceded by an SMS 48 hours before.
The desired effect was an increase in the percentage of successful calls at 3 months, allowing for possible evaluations at 3 months in order to identify, evaluate and accompany subjects still in a suicidal crisis and thus avoid a recurrence of the act and thus a suicide.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Naoual MELLOUKI BENDIM'RED, PhD
- Phone Number: 0033 0383925267
- Email: unic@cpn-laxou.com
Study Contact Backup
- Name: Xavier SIPP
- Phone Number: 0033 03.83.85.16.58
- Email: xavier.sipp@cpn-laxou.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having made a suicide attempt (first-time suicide or not)
- Hosted at the Central Hospital of Nancy
- Included in the "VigilanS Lorraine" monitoring system
Not presenting criteria for non-inclusion in the "VigilanS Lorraine" system, namely:
- Guardianship
- Held
- Dementia
- Not speaking French
- Subject having received information relating to the progress of the EVAREST 3 study and having given their consent to participate
- Subject affiliated or entitled to a social security scheme
Exclusion Criteria:
- Subject without mobile phone
- Participation in another interventional study on the prevention of suicidal recidivism
- Subject under curatorship who was not assisted by his curator to give his consent to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SMS
Sending an SMS 48 hours before the 3-month evaluation call planned as part of the VigilanS Lorraine system
|
Each subject of the experimental group will receive, in addition to the usual procedure of the VigilanS Lorraine device, an SMS 48 hours before the telephone call for evaluation at 3 months, warning him of this call. The time of this SMS has been set at 1:00 p.m. for all the people included in this group. At the end of this evaluation call, the caller will pass a satisfaction questionnaire to the subject in relation to the sending of the SMS |
|
No Intervention: Without SMS
without Sending an SMS 48 hours before the 3-month evaluation call planned as part of the VigilanS Lorraine system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of successful calls during the 3 month evaluation
Time Frame: 3 months
|
. A call is considered unsuccessful after 3 call attempts at 3 different times over 3 consecutive working days.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction survey
Time Frame: 3 months
|
subjective experience of the subject having benefited from the sending of the SMS in relation to the intervention, the delay between the sending of the SMS and the telephone call
|
3 months
|
|
SMS delivery status:
Time Frame: 3 months
|
issued/not issued
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xavier SIPP, Mr., Centre Psychothérapique de Nancy
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-A01404-39
- RIPH-2022-02 (Other Identifier: Centre Psychothérapique de Nancy)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide, Attempted
-
Brown UniversityButler HospitalCompleted
-
Vastra Gotaland RegionGöteborg UniversityRecruitingSuicidal Ideation | Suicide | Suicide AttemptSweden
-
University of BernCompletedSuicidal Ideation | Suicide | Suicide AttemptSwitzerland
-
Vestre Viken Hospital TrustNorwegian Institute of Public Health; Helse Sor-Ost; The Catholic University...Completed
-
Hillerod Hospital, DenmarkUnknownHepatic InjuryDenmark
-
Pakistan Institute of Living and LearningUniversity of Manchester; Dow University of Health Sciences; Abbasi Shaheed HospitalCompletedDepression | Attempted SuicidePakistan
-
Karolinska InstitutetRecruitingSuicide, Attempted | Suicidal and Self-injurious Behavior | Suicide Attempt | Suicide AttemptedSweden
-
Boston Children's HospitalAmerican Foundation for Suicide PreventionCompletedAlcohol Drinking | SuicideUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR); Trustees of Dartmouth CollegeNot yet recruitingSuicide Attempt | Suicide IdeationUnited States
-
University of Sao PauloNot yet recruitingSuicide Ideation | Suicide Attempts
Clinical Trials on IMPACT OF SENDING AN SMS
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompletedLow Trauma Non Vertebral FractureFrance
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Hospital do CoracaoHospital Moinhos de VentoActive, not recruiting
-
Karolinska InstitutetRegion SkaneRecruitingNeoplasms | Neoplasms by Site | Cervical Cancer | Uterine Neoplasms | Uterine Diseases | Genital Diseases, Female | Uterine Cervical Neoplasm | Uterine Cervical Disease | Genital Neoplasm, Female | Genital NeoplasmSweden
-
University Hospital, LimogesCompleted
-
Martin AngstCompletedImmunityUnited States
-
Terrence JonesNestléCompletedLaryngeal Squamous Cell Carcinoma | Squamous Cell Carcinoma of Oropharynx | Squamous Cell Carcinoma of Mouth | Squamous Cell Carcinoma of the HypopharynxUnited Kingdom
-
Nantes University HospitalCompletedPatients at Risk for MelanomaFrance
-
University Hospital, Clermont-FerrandUniversity Clermont Auvergne (UCA), Clermont-Ferrand, France; LaPSCO laboratory...RecruitingStress | Heart Rate VariabilityFrance
-
University Hospital, AngersNot yet recruitingDysraphism | Open Dysraphism | Closed Dysraphism